TY - JOUR
T1 - Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups
AU - Bogani, Giorgio
AU - Apolone, Giovanni
AU - Ditto, Antonino
AU - Scambia, Giovanni
AU - Panici, Pierluigi Benedetti
AU - Angioli, Roberto
AU - Pignata, Sandro
AU - Greggi, Stefano
AU - Scollo, Paolo
AU - Delia, Mezzanzanica
AU - Franchi, Massimo
AU - Martinelli, Fabio
AU - Signorelli, Mauro
AU - Lopez, Salvatore
AU - Di Donato, Violante
AU - Valabrega, Giorgio
AU - Ferrandina, Gabriella
AU - Palaia, Innocenza
AU - Bergamini, Alice
AU - Bocciolone, Luca
AU - Savarese, Antonella
AU - Ghezzi, Fabio
AU - Casarin, Jvan
AU - Pinelli, Ciro
AU - Trojano, Vito
AU - Chiantera, Vito
AU - Giorda, Giorgio
AU - Sopracordevole, Francesco
AU - Malzoni, Mario
AU - Salerno, Giovanna
AU - Sartori, Enrico
AU - Testa, Antonia
AU - Zannoni, Gianfranco
AU - Zullo, Fulvio
AU - Vizza, Enrico
AU - Trojano, Giuseppe
AU - Chiantera, Antonio
AU - Raspagliesi, Francesco
PY - 2020/11/1
Y1 - 2020/11/1
N2 - OBJECTIVE: Coronavirus disease 2019 (COVID-19) has caused rapid and drastic changes in cancer management. The Italian Society of Gynecology and Obstetrics (SIGO), and the Multicenter Italian Trials in Ovarian cancer and gynecologic malignancies (MITO) promoted a national survey aiming to evaluate the impact of COVID-19 on clinical activity of gynecologist oncologists and to assess the implementation of containment measures against COVID-19 diffusion. METHODS: The survey consisted of a self-administered, anonymous, online questionnaire. The survey was sent via email to all the members of the SIGO, and MITO groups on April 7, 2020, and was closed on April 20, 2020. RESULTS: Overall, 604 participants completed the questionnaire with a response-rate of 7019 outbreak. Triage methods were adopted in order to minimize in-hospital diffusion of COVID-19. Only 3819 outbreak. Although 7319 has not significantly modified their everyday practice, 2119. However, less than 5019. Additionally, responders suggested to delay cancer treatment (1015, and to perform less radical surgical procedures (2025 during COVID-19 pandemic. CONCLUSIONS: National guidelines should be implemented to further promote the safety of patients and health care providers. International cooperation is of paramount importance, as heavily affected nations can serve as an example to find out ways to safely preserve clinical activity during the COVID-19 outbreak.
AB - OBJECTIVE: Coronavirus disease 2019 (COVID-19) has caused rapid and drastic changes in cancer management. The Italian Society of Gynecology and Obstetrics (SIGO), and the Multicenter Italian Trials in Ovarian cancer and gynecologic malignancies (MITO) promoted a national survey aiming to evaluate the impact of COVID-19 on clinical activity of gynecologist oncologists and to assess the implementation of containment measures against COVID-19 diffusion. METHODS: The survey consisted of a self-administered, anonymous, online questionnaire. The survey was sent via email to all the members of the SIGO, and MITO groups on April 7, 2020, and was closed on April 20, 2020. RESULTS: Overall, 604 participants completed the questionnaire with a response-rate of 7019 outbreak. Triage methods were adopted in order to minimize in-hospital diffusion of COVID-19. Only 3819 outbreak. Although 7319 has not significantly modified their everyday practice, 2119. However, less than 5019. Additionally, responders suggested to delay cancer treatment (1015, and to perform less radical surgical procedures (2025 during COVID-19 pandemic. CONCLUSIONS: National guidelines should be implemented to further promote the safety of patients and health care providers. International cooperation is of paramount importance, as heavily affected nations can serve as an example to find out ways to safely preserve clinical activity during the COVID-19 outbreak.
M3 - Article
SN - 2005-0380
JO - Journal of Gynecologic Oncology
JF - Journal of Gynecologic Oncology
IS - 6
ER -